Prostatype Genomics AB
556726-0285ActiveGenomic classifier test guides prostate cancer treatment decisions for patients.
Genomics / Biotechnology Companyprostatype.com
Yleiskatsaus
- 5–9
- Työntekijät
- 200–299t SEK
- Liikevaihto
- 2007
- Perustettu
Kuvaus
Prostatype Genomics is a specialized biotechnology company focused on improving outcomes for men diagnosed with localized prostate cancer. They provide the Prostatype® Genomic Classifier (PGC™), a next-generation prognostic test developed from extensive research at the Karolinska Institute. This non...
Tunnisteet
B2BB2CPharmaceuticalsHealthTech